Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON49777Not yet recruiting
Open-label, single-arm trial in hidradenitis suppurativa (HS), sponsored by Erasmus MC. Primary endpoint: Change in gene expression profile. Planned start Jul 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON49777.